Canaccord Genuity Maintains Buy on Privia Health Gr, Raises Price Target to $34
Benzinga Newsdesk 11 months ago
NewsPrice TargetAnalyst Ratings
Canaccord Genuity analyst Richard Close maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and raises the price target from $32 to $34.
Canaccord Genuity analyst Richard Close maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and raises the price target from $32 to $34.